Skip to Main Content
Table 1—

Baseline characteristics of participating adolescents by group

HRQoL intervention groupControl group
Patients (n41 40 
Girls/boys (n19/22 19/21 
Age (years) 14.8 ± 1.1 14.9 ± 1.0 
BMI (kg/m221.1 ± 3.6 21.1 ± 3.0 
Diabetes duration (years) 7.2 ± 4.3 6.2 ± 4.3 
Injections per day (%)   
    2 9.8 
    3 51.2 30 
    4 29.3 45 
    Pump 9.8 20 
A1C (%) 8.6 ± 1.4 8.8 ± 1.3 
Single-parent families (n
Ethnic minority (n
HRQoL intervention groupControl group
Patients (n41 40 
Girls/boys (n19/22 19/21 
Age (years) 14.8 ± 1.1 14.9 ± 1.0 
BMI (kg/m221.1 ± 3.6 21.1 ± 3.0 
Diabetes duration (years) 7.2 ± 4.3 6.2 ± 4.3 
Injections per day (%)   
    2 9.8 
    3 51.2 30 
    4 29.3 45 
    Pump 9.8 20 
A1C (%) 8.6 ± 1.4 8.8 ± 1.3 
Single-parent families (n
Ethnic minority (n

Data are means ± SD unless otherwise indicated. There were no significant differences between the HRQoL intervention and control group.

Close Modal

or Create an Account

Close Modal
Close Modal